Fluidda.com Website Review

Functional Respiratory Imaging (FRI) is a imaging technology which enhances drug development and patient care by providing Functional Respiratory Imaging (FRI) is a imaging technology which enhances drug development and patient care by providing FRI reduces the cost and time required for screening most promising new respiratory drugs in early clinical phase FRI is sensitive and identifies more quickly inefficient therapies, improving patient care FRI reduces the cost and time required for screening most promising new respiratory drugs in early clinical phase FRI is sensitive and identifies more quickly inefficient therapies, improving patient care “FLUIDDA’s technique and insights to the subject were outstanding. We were delighted with the science and collaboration we had with “FLUIDDA’s technology is an important tool which helps bridge data from in vitro and in vivo studies.“ Dr. Paul M. Dorinsky – Head Global Respiratory Clinical Development, Cipla “FLUIDDA’s technique and insights to the subject were outstanding. We were delighted with the science and collaboration we had with “FLUIDDA’s technology is an important tool which helps bridge data from in vitro and in vivo studies.“ Dr. Paul M. Dorinsky – Head Global Respiratory Clinical Development, Cipla A thorough understanding of a pharmaceutical company’s target disease is imperative when it wants to successfully develop and market We’ve said it before: the respiratory field is the most expensive one in the pharmaceutical world. The low sensitivity of